Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barker

Showing results (611-620 of 649) with videos related to

Pageof 65
Sort By:
BMC Cancer|February 2, 2017
HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentationMartin McLaughlin, Holly E Barker, Aadil A Khan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 28, 2021
Integrating Home-Based Exercise Training with a Hospital at Home Service for Patients Hospitalised with Acute Exacerbations of COPD: Developing the Model Using Accelerated Experience-Based Co-DesignRuth E Barker, Lisa J Brighton, Matthew Maddocks, et al.
Journal of Drug Targeting|October 28, 2004
Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage displayMichele J Writer, Barry Marshall, Michael A Pilkington-Miksa, et al.
Respirology (Carlton, Vic.)|March 23, 2023
Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort studyClaire M Nolan, Susie J Schofield, Matthew Maddocks, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammationGraeme O'Boyle, Christopher R J Fox, Hannah R Walden, et al.
Clinical Pharmacokinetics|November 26, 2014
Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjectsPeter J Rix, Andrew Vick, Neil J Attkins, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
AIDS (London, England)|September 10, 2002
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDSChristina M Marra, Natasa Rajicic, David E Barker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2005
Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitisCathryn A Broderick, Alexander J Smith, Kam S Balaggan, et al.
The European Respiratory Journal|April 30, 2021
Gait speed and adverse outcomes following hospitalised exacerbation of COPDJessica A Walsh, Ruth E Barker, Samantha S C Kon, et al.
Pageof 65

Showing results (611-620 of 649) with videos related to

Sort By:
Pageof 65
BMC Cancer|February 2, 2017
HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentationMartin McLaughlin, Holly E Barker, Aadil A Khan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 28, 2021
Integrating Home-Based Exercise Training with a Hospital at Home Service for Patients Hospitalised with Acute Exacerbations of COPD: Developing the Model Using Accelerated Experience-Based Co-DesignRuth E Barker, Lisa J Brighton, Matthew Maddocks, et al.
Journal of Drug Targeting|October 28, 2004
Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage displayMichele J Writer, Barry Marshall, Michael A Pilkington-Miksa, et al.
Respirology (Carlton, Vic.)|March 23, 2023
Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort studyClaire M Nolan, Susie J Schofield, Matthew Maddocks, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammationGraeme O'Boyle, Christopher R J Fox, Hannah R Walden, et al.
Clinical Pharmacokinetics|November 26, 2014
Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjectsPeter J Rix, Andrew Vick, Neil J Attkins, et al.
Gene Therapy|March 31, 2006
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNVK S Balaggan, K Binley, M Esapa, et al.
AIDS (London, England)|September 10, 2002
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDSChristina M Marra, Natasa Rajicic, David E Barker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2005
Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitisCathryn A Broderick, Alexander J Smith, Kam S Balaggan, et al.
The European Respiratory Journal|April 30, 2021
Gait speed and adverse outcomes following hospitalised exacerbation of COPDJessica A Walsh, Ruth E Barker, Samantha S C Kon, et al.
Pageof 65